4-{7-[4-(hydroxymethyl)phenyl]-1-isopropyl-1H-indazol-3-yl}-3-methylphenol | 680614-20-4

• 分子结构分类: 有机化合物
• 英文名称: 4-{7-[4-(hydroxymethyl)phenyl]-1-isopropyl-1H-indazol-3-yl}-3-methylphenol
• 英文别名: 4-[7-[4-(Hydroxymethyl)phenyl]-1-propan-2-ylindazol-3-yl]-3-methylphenol
• CAS: 680614-20-4
• 化学式: C₂₄H₂₄N₂O₂
• 分子量: 372.467
• InChiKey: RUVXEFJGLKHQTC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  58.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Method of treating or preventing myocardial ischemia-reperfusion injury using NF-kB inhibitors
  申请人：Chadwick Cyril Christopher

  公开号：US20060111421A1

  公开（公告）日：2006-05-25

  The present invention concerns a method of treatment or prevention of myocardial ischemia-reperfusion injury by diagnosing that a person is in need of treatment or prevention of myocardial ischemia-reperfusion injury and administering a therapeutically effective amount of a ligand which modulates NF-kB transcription factor by interaction with estrogen receptor ER-α, estrogen receptor ER-β, or both ER-α and ER-β estrogen receptors with a substantial absence of creatine kinase stimulation. In certain preferred embodiments, the administration is substantially without uterotropic activity.

  本发明涉及一种治疗或预防心肌缺血再灌注损伤的方法，通过诊断一个人需要治疗或预防心肌缺血再灌注损伤，并通过与雌激素受体ER-α、雌激素受体ER-β或ER-α和ER-β雌激素受体中的一个或两个相互作用来给予调节NF-kB转录因子的配体的治疗有效量，其中刺激肌酸激酶的作用显著缺乏。在某些优选实施例中，给药基本上不具有子宫营养活性。
• [EN] SUBSTITUTED 4-(INDAZOL-3-YL)PHENOLS AS ESTROGEN RECEPTOR (ER) LIGANDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] 4-(INDAZOL-3-YL)PHENOLS SUBSTITUES COMME LIGANDS DU RECEPTEUR DES OESTROGENES ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES
  申请人：WYETH CORP

  公开号：WO2004031159A1

  公开（公告）日：2004-04-15

  This invention provides compound of formulae I or II having the structure wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease. Arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.

  这项发明提供了具有结构的化合物I或II的公式，其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10如规范中定义，或其药用盐，这些化合物对治疗疾病的炎症成分有用，特别适用于治疗动脉粥样硬化、心肌梗死、充血性心力衰竭、炎症性肠病、关节炎、2型糖尿病以及多发性硬化和类风湿关节炎等自身免疫疾病。
• Substituted 4-(indazol-3-yl)phenols
  申请人：Wyeth

  公开号：US20040167127A1

  公开（公告）日：2004-08-26

  This invention provides compound of formulae I or II having the structure 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.

  本发明提供了式I或式II的化合物，其结构为1，其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10如规范中所定义，或其药学上可接受的盐，其对于疾病的炎症成分具有治疗作用，尤其是在治疗动脉粥样硬化、心肌梗死、充血性心力衰竭、炎症性肠病、关节炎、2型糖尿病以及自身免疫性疾病如多发性硬化和类风湿性关节炎方面特别有用。
• Substituted 4-(Indazol-3-yl)phenols
  申请人：Steffan J. Robert

  公开号：US20070225349A1

  公开（公告）日：2007-09-27

  This invention provides compound of formulae I or II having the structure wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.

  该发明提供了式I或II的化合物，其结构为： 其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10如规范中所定义，或其药学上可接受的盐，用于治疗疾病的炎症成分，特别适用于治疗动脉硬化、心肌梗塞、充血性心力衰竭、炎症性肠病、关节炎、II型糖尿病以及多发性硬化和风湿性关节炎等自身免疫疾病。
• SUBSTITUTED 4-(INDAZOL-3-YL)PHENOLS AS ESTROGEN RECEPTOR (ER) LIGANDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES
  申请人：Wyeth

  公开号：EP1542976B1

  公开（公告）日：2009-02-04